Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ANDRX CORP (ADRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/13/2006 8-K Quarterly results
08/09/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2006 SECOND QUARTER"
07/10/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Letter agreement dated July 7, 2006, by and among Watson Pharmaceuticals, Inc., a Nevada corporation, Water Delaware, Inc., and Andrx Corporation, a Delaware corporation",
"WATSON AND ANDRX AMEND MERGER AGREEMENT - Deadline Extended to November 13, 2006 to Allow for Further FTC Review -"
05/05/2006 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2006 FIRST QUARTER"
05/03/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "WATSON PHARMACEUTICALS and ANDRX CORPORATION RECEIVE FTC SECOND REQUEST"
04/25/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "4"
04/19/2006 8-K Other Events
03/17/2006 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
Docs: "ANDRX CORPORATION REPORTS FINANCIAL RESULTS FOR 2005 FOURTH QUARTER AND FULL YEAR"
03/16/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "0",
"0",
"0",
"0"
03/13/2006 8-K Other Events
03/13/2006 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Agreement and Plan of Merger by and among Watson Pharmaceuticals, Inc., Water Delaware, Inc. and Andrx Corporation",
"Amendment to Rights Agreement between Andrx Corporation and American Stock Transfer & Trust Company",
"Andrx to be acquired by Watson for $25.00 Per Share"
03/06/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "8"
01/23/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "Andrx Granted Summary Judgment for Generic Toprol-XL"
01/13/2006 8-K Entry into a Material Definitive Agreement
12/16/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "6"
12/15/2005 8-K Other Events
11/16/2005 8-K Other Events
11/08/2005 8-K Quarterly results
Docs: "ANDRX CORPORATION REPORTS 2005 THIRD QUARTER RESULTS"
10/19/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "Letter to Andrx customers"
09/29/2005 8-K Termination of a Material Definitive Agreement
09/23/2005 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Andrx Announces Change in Chief Financial Officer FORT LAUDERDALE, Fla. - September 20, 2005 — Andrx Corporation"
09/21/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "3"
09/06/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "ANDRX REPORTS ON FDA DEVELOPMENTS"
07/29/2005 8-K Quarterly results
Docs: "ANDRX CORPORATION REPORTS 2005 SECOND QUARTER RESULTS"
05/06/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "ANDRX ENTERS INTO ALLIANCE FOR GENERIC LOVENOX WITH AMPHASTAR"
05/05/2005 8-K Quarterly results
Docs: "PRESS RELEASE DATED MA4 4, 2005"
04/18/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Summary of RSU Awards to Named Executive Officers"
04/14/2005 8-K Other Events
04/07/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Summary of Compensation Matters related to Named Executive Officers"
03/23/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Summary Discussion of Restricted Stock Unit Grants to Non-Employee Directors on March 17, 2005"
03/09/2005 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "ANDRX REPORTS FOURTH QUARTER 2004 AND FULL YEAR FINANCIAL RESULTS"
03/08/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amended and Restated Employment Agreement between Andrx Corporation and Larry Rosenthal",
"Andrx to Divest Altoprev and Fortamet to First Horizon Pharmaceutical Corporation"
01/06/2005 8-K Termination of a Material Definitive Agreement, Cost Associated with Exit or Disposal Activities, Financial Statements and Ex...
Docs: "Andrx To Focus on Generic and Distribution Businesses To Exit Brand Business"
11/18/2004 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Cessation Agreement between Andrx Corporation and Elliot F. Hahn, Ph.D."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy